Failure of immunologic purging in mantle cell lymphoma assessed by polymerase chain reaction detection of minimal residual disease

Blood

Volumn 90, Issue 10, 1997, Pages 4212-4221

  Andersen, Niels S ^b   Donovan, John W ^b   Borus, Joseph S ^b   Poor, Christina M ^b   Neuberg, Donna ^b   Aster, Jon C ^b   Nadler, Lee M ^b   Freedman, Arnold S ^b   Gribben, John G ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; MALE; MALIGNANT TRANSFORMATION; MANTLE CELL LYMPHOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOMATIC MUTATION; TUMOR CELL;

EID: 0030817398     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.10.4212     Document Type: Article

References (45)

1. Weisenburger DD, Armitage JO: Mantle cell lymphoma - An entity comes of age. Blood 87:4483, 1996
2. Banks PM, Chan J, Cleary ML, Delsol G, De Wolf-Peeters C, Gatter K, Grogan TM, Harris NL, Isaacson PG, Jaffe ES, Mason D, Pileri S, Ralfkiaer E, Stein H, Warnke RA: Mantle cell lymphoma: A proposal for unification of morphologic, immunologic and molecular data. Am J Surg Pathol 16:637, 1992
3. Zucca E, Fontana S, Roggero E, Pedrinis E, Pampalona S, Cavalli F: Treatment and prognosis of centrocytic (mantle cell) lymphoma: A retrospective analysis of twenty six patients treated in one institution. Leukemia Lymphoma 13:105, 1994
4. Pittaluga S, Wloddarska I, Stul MS, Thomas T, Verhoef G, Cassiman J, van der Berghe H, de Wolf-Peeters C: Mantle cell lymphoma: A clinicopathological study of 55 cases. Histopathology 26:17, 1995
5. Velders GA, Kluin-Nelemans JC, DeBoer CJ, Hermans J, Noordijk EM, Schuuring E, Kramer MHH, VanDeijk WA, Rahder JB, Kluin PM, Van Krieken JHJM: Mantle cell lymphoma: A population-based clinical study. J Clin Oncol 14:1269, 1996
6. Fisher RI, Dahlberg S, Nathwani BN, Banks PM, Miller TP, Grogan TM: A clinical analysis of two indolent lymphoma entities: Mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): A southwest oncology group study. Blood 85:1075, 1995
7. Teodorovic I, Pittaluga S, Kluin-Nelemans JC, Meerwalt JH, Hagenbeek A, von Glabbeke M, Somers R, Bijnens L, Noordik EM, de Wolf-Peeters C: Efficacy of four different regimens in 64 mantle-cell lymphoma cases: Clinicopathologic comparison with 498 other non-Hodgkin's lymphoma subtypes. J Clin Oncol 13:2819, 1995
8. Zucca E, Roggero E, Pinotti G, Pedrinis E, Cappella C, Venco A, Cavalli F: Patterns of survival in mantle cell lymphoma. Ann Oncol 6:257, 1995
9. Garcia-Conde J, Cabanillas F: Mantle cell lymphoma: A lymphoproliferative disorder associated with aberrant function of the cell cycle. Leukemia 10:78, 1996 (suppl 2)
10. Stewart DA, Vose JM, Weisenburger DD, Anderson JR, Ruby EI, Bast MA, Bierman PJ, Kessinger A, Armitage JO: The role of high dose therapy and autologous hematopoietic stem cell transplantation for mantle cell lymphoma. Ann Oncol 6:263, 1995
11. Tsujimoto Y, Yunis J, Onorato-Showe L, Erikson J, Nowell PC, Croce CM: Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;14) chromosome translocation. Science 224:1403, 1984
12. Tsujimoto Y, Jaffe E, Cossman J, Gorham J, Nowell PC, Croce CM: Clustering of breakpoints on chromosome 11 in human B-cell neoplasms with the t(11;14) chromosome translocation. Science 315:340, 1985
13. Harris AW, Bodrug SE, Warner BJ, Bath ML, Lindeman GJ, Adams JM: Cyclin D1 as the putative bcl-1 oncogene. Curr Top Microbiol Immunol 194:347, 1995
14. Bigoni R, Negrini M, Veronese ML, Cuneo A, Castoldi GL, Croce CM: Characterization of t(11;14) translocation in mantle cell lymphoma by fluorescent in situ hybridization. Oncogene 13:797, 1996
15. Williams ME, Swerdlow SH, Meeker TC: Chromosome t(11;14) breakpoints in centrocytic lymphoma are highly localized at the bcl-1 major translocation cluster. Leukemia 7:1437, 1993
16. Rimokh R, Berger F, Delsol G, Digonnet I, Rouault JP, Tigaud JD, Gadoux M, Coiffier B, Bryon PA, Magaud JP: Detection of the chromosomal translocation t(11;14) by polymerase chain reaction in mantle cell lymphomas. Blood 83:1871, 1994
17. Molot RJ, Meeker TC, Wittwer CT, Perkins SL, Segal GH, Masih AS, Braylan RC, Kjeldsberg CR: Antigen expression and polymerase chain reaction amplification of mantle cell lymphoma. Blood 83:1626, 1994
18. Segal GH, Masih AS, Fox AC, Jorgenson T, Scott M, Braylan RC: CD5-expressing B cell non Hodgkin's lymphomas with bcl-1 gene rearrangement have a relatively homogeneous immunopheno-type and are associated with an overall poor prognosis. Blood 85:1570, 1995
19. Deane M, McCarthy KP, Wiedemann LM, Norton JD: An improved method for detection of B-lymphoid clonality by polymerase chain reaction. Leukemia 5:726, 1991
20. Provan D, Zwicky C, Bartlett-Pandite L, Maddocks A, Corradini P, Soiffer R, Ritz J, Nadler LM, Gribben JG: Eradication of PCR detectable chronic lymphocytic leukemia cells is associated with improved outcome after bone marrow transplantation. Blood 88:2228, 1996
21. Zwicky C, Maddocks A, Andersen N, Gribben JG: PCR detection of immunoglobulin gene rearrangements in non-Hodgkin's lymphoma: Persistence after autologous bone marrow transplantation predicts for relapse. Blood 88:1996
22. Gribben JG, Freedman A, Woo SD, Blake K, Shu RS, Freeman G, Longtine JA, Pinkus GS, Nadler LM: All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment. Blood 78:3275, 1991
23. Griggen JG, Freedman AS, Neuberg D, Roy DC, Blake KW, Woo SD, Grossbard ML, Rabinowe SN, Coral F, Freeman GJ, Ritz JK, Nadler LM: Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N Engl J Med 325:1525, 1991
24. Gribben JG, Neuberg D, Barber M, Moore J, Pesek KW, Freedman AS, Nadler LM: Detection of residual lymphoma cells by polymerase chain reaction in peripheral blood is significantly less predictive for relapse than detection in bone marrow. Blood 83:3800, 1994
25. Corradini P, Ladetto M, Astolfi M, Voena C, Tarella C, Bacigallupo A, Pileri A: Clinical and molecular remission after allogeneic blood cell transplantation in a patient with mantle-cell lymphoma. Br J Haematol 94:376, 1996
26. Gearhart PJ, Bogenhagen DF: Cluster of point mutations are found exclusively around rearranged antibody variable genes. Proc Natl Acad Sci USA 80:3439, 1983
27. Zelenetz AD, Chen TT, Levy R: Clonal expansion in follicular lymphoma occurs subsequent to antigenic selection. J Exp Med 176:1137, 1992
28. Bakkus MH, Heirman C, Van RI, Van CB, Thielemans K: Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation. Blood 80:2326, 1992
29. Sahota SS, Leo R, Hamblin TJ, Stevenson FK: Myeloma VI and VH gene sequences reveal a complementary imprint of antigen selection in tumor cells. Blood 89:219, 1997
30. Varde W, Marin E, Milano M, Insel R, Swerdlow S, Williams M: VH gene repertoire of Mantle cell lymphomas. Ann NY Acad Sci 764:504, 1993
31. Hummel M, Tamaru J, Kalvelage B, Stein H: Mantle cell (previous centrocytic) lymphomas express VH genes with no or very little somatic mutations like the physiologic cells of the follicle mantle. Blood 84:403, 1994
32. Gribben JG, Neuberg D, Freedman AS, Gimmi CD, Pesek KW, Barber M, Saporito L, Woo SD, Coral F, Spector N, Rabinowe SN, Grossbard ML, Ritz J, Nadler LM: Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma. Blood 81:3449, 1993
33. Kabat EA, Wu TT, Perry HM, Gottesman KS, Foeller C: Sequences of Proteins of Immunological Interest. Washington, DC, Department of Health and Human Services, National Institutes of Health, 1991
34. Shlomchik MJ, Aucoin AH, Pisetsky DS, Weigert MG: Structure and function of anti-DNA autoantibodies derived from a single autoimmune mouse. Proc Natl Acad Sci USA 84:9150, 1987
35. Chan B, Casali P: The CDRI sequences of a major proportion of human germline Ig VH genes are inherently susceptible to amino acid replacement. Immunol Today 15:367, 1994
36. Luthra R, Hai S, Pugh WC: Polymerase chain reaction detection of the t(11;14) translocation involving the bcl-1 major translocation cluster in mantle cell lymphoma. Diagn Mol Pathol 4:4, 1995
37. Zucca E, Soldati G, Schlegelberger B, Booth MJ, Weber-Matthiesen K, Cavalli F, Cotter FE: Detection of chromosome 11 alterations in blood and bone marrow by interphase cytogenetics in mantle cell lymphoma. Brit J Haematol 89:665, 1995
38. Williams ME, Zukerberg LR, Harris NL, Yang WI, Arnold A, Finkelstein SD, Swerdlow SH: Mantle cell/centrocytic lymphoma: Molecular and phenotypic analysis including analysis of the bcl-1 major translocation cluster by PCR. Curr Top Microbiol Immunol 194:341, 1995
39. Bahler DW, Levy R: Clonal evolution of a follicular lymphoma: Evidence for antigen selection. Proc Natl Acad Sci USA 89:6770, 1992
40. + B cell lines. Eur J Immunol 21:1115, 1991
41. Kipps TJ: Immunoglobulin genes in chronic lymphocytic leukemia. Blood Cells 19:615, 1993
42. Freedman AS, Gribben JG, Neuberg D, Mauch P, Soiffer RJ, Anderson KC, Pandite L, Robertson MJ, Kroon M, Ritz J, Nadler LM: High dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission. Blood 88:2780, 1996
43. Gribben JG, Saporito L, Barber M, Blake KW, Edwards RM, Griffin JD, Freedman AS, Nadler LM: Bone marrows of non-Hodgkin's lymphoma patients with a bcl-2 translocation can be purged of polymerase chain reaction-detectable lymphoma cells using monoclonal antibodies and immunomagnetic bead depletion. Blood 80:1083, 1992
44. Deisseroth AB, Zu Z, Claxton D, Hanania EG, Fu S, Ellerson D, Goldberg L, Thomas M, Janicek K, Anderson WF, Hester J, Korbling M, Durett A, Moen R, Berenson R, Heimfeld S, Hamer J, Calvert L, Tibbits P, Talpaz M, Kantarjian H, Champlin R, Reading C: Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood 83:3068, 1994
45. Brenner MK, Rill DR, Moen RC, Krance RA, Mirro J, Anderson WF, Ihle JN: Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 341:85, 1993